FIM study

We have succesfully finished our first First in Man study with psychoactive, anti-depressive substance, which is expected to be a breakthrough in depression treatment.

The study is conducted for one of the most promising Polish phramaceutical companies,  as a part of NCBiR programme.

Go back

News

Annual GCP training

On 24th of March, 2018 we have organized the second annual GCP training for all our employees and co-workers.

Read more …

First phase study

We have just succesfully finished the second part of the first phase study with no Serious Adverse Events.

Read more …

Bioequivalence study

We have just finished clinical part of one of our ongoing bioequivalence Clinical Studies.

Read more …

Membership in SCRS

We have joined the Society for Clinical Research Sites (SCRS)!

 

Read more …

Open Recruitment to new study

We have started new study with testosterone for healthy Volunteers or Patients with testosterone deficiency.

Read more …

About Us | Services | Our Site | Partners | Smoking Risk Study | Contact Us

Early Phase Clinical Trials

2022 © Bio Research Group. All rights reserved.

 

scroll to top ▲